CoreHip - Post Market Clinical Follow-Up Study

Aesculap

Status: Active, not recruiting

Conditions: Rheumatic Arthritis; Degenerative Osteoarthritis; Fractures, Hip; Necrosis, Femur Head

Treatments: Device: CoreHip Total Hip Arthroplasty

Study type: Observational

Funder types: Industry

Identifiers

NCT03685110

AAG-O-H-1509

Details and patient eligibility

About

The study is designed as a prospective, non-interventional multicentre cohort study. The product under Investigation will be used in Routine clinical practice and according to the authorized Instructions for Use (IfU). Aim of this observational study is to collect clinical and radiological results of the CoreHip® endoprosthesis system in a Standard Patient Population and when used in Routine clinical practice.

Full description

The CoreHip® System has a range of different stem designs to address most of the indications and anatomical conditions met in Primary THA patients within one implant and Instrument System.

Enrollment: 248 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient age ≥ 18 years
• Indication for THA with a CoreHip® stem
• Written informed consent

Exclusion criteria

• Pregnancy
• Patient age < 18 years
• Patient not able to regularly participate at the follow-up examinations

Trial design

248 participants in 1 patient group

CoreHip

Description:

Clinical and Radiological Data of 300 patients of a Standard Patient Population, who are treated with CoreHip Total Hip Arthroplasty for Indications according to the Instructions for Use (IfU) with a five year follow Up

Treatment:

Device: CoreHip Total Hip Arthroplasty